Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.7 |
mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.066 | 0.7 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.064 | 0.7 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.047 | 0.7 |